Global Bioresorbable Scaffolds Market Size, Share, Growth Analysis, By Type(Drug Eluting Coronary Scaffolds, Sirolimus-Eluting Device), By Material(Absorbable Magnesium Stent (AMS), Polymeric Scaffold) - Industry Forecast 2024-2031

Global Bioresorbable Scaffolds Market size was valued at USD 374.94 million in 2022 and is poised to grow from USD 416.56 million in 2023 to USD 966.92 million by 2031, growing at a CAGR of 11.10% during the forecast period (2024-2031).

The bioresorbable scaffolds market is experiencing substantial growth attributed to advancements in medical technology and the rising prevalence of cardiovascular diseases. These scaffolds, temporary implants utilized for treating coronary artery diseases, gradually dissolve over time, facilitating natural vessel healing. The market is categorized by material type, application, end-user, and region. Polymer-based scaffolds, dominating the material type segment due to their biocompatibility and gradual resorption, lead the market. The application segment, encompassing cardiovascular diseases, orthopedic disorders, and others, sees cardiovascular diseases as the primary driver due to a high incidence rate. End-users include hospitals, ambulatory surgical centers, and specialized clinics, with increasing hospital admissions for cardiac interventions boosting scaffold demand. Geographically, North America holds a significant market share, driven by well-established healthcare infrastructure and a rising number of cardiovascular cases. Europe follows with a focus on research and development, while the Asia-Pacific region sees growth due to increased healthcare investments and an aging population. Market growth drivers include the growing elderly population, demand for minimally invasive procedures, and technological advancements. However, challenges such as high costs and the need for skilled professionals pose hindrances to market expansion. Ongoing research to enhance scaffold properties and efficacy is expected to drive the bioresorbable scaffolds market in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioresorbable Scaffolds Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioresorbable Scaffolds Market Segmental Analysis

The Bioresorbable Scaffolds market is segmented on the basis of disease type, treatment, end-user, and regional. Based on Disease Type the market is segmented as, Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO). Based on Treatment the market is segmented as, Anti-vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, And Others. Based on End-user the market is segmented as, Hospital & Clinics, Research and Academics, Others. Based on Regional the market is segmented as, North America, Asia Pacific, Latin America.

Drivers of the Global Bioresorbable Scaffolds Market

The increasing occurrence of cardiovascular diseases, including conditions like coronary artery disease and peripheral artery disease, plays a pivotal role in propelling the bioresorbable scaffolds market forward. To address these ailments and restore proper blood flow, there is a growing need for advanced treatments, fueling the demand for inventive solutions such as bioresorbable scaffolds.

Restraints in the Global Bioresorbable Scaffolds Market

The bioresorbable scaffolds market encounters a hurdle due to the scarcity of extensive long-term clinical data. The effectiveness and safety of bioresorbable scaffold implants relative to traditional stents require additional assessment for a conclusive understanding, emphasizing the need for further evaluation to establish their efficacy and safety over an extended period.

Market Trends of the Global Bioresorbable Scaffolds Market

The growing population of elderly individuals necessitates an increased frequency of healthcare services, leading to a rising demand for bioresorbable scaffolds. This is particularly crucial as older people tend to be more susceptible to cardiovascular diseases, highlighting the importance of advanced medical solutions to address their specific healthcare needs.